We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Galapagos Expands its Collaboration with Serono
News

Galapagos Expands its Collaboration with Serono

Galapagos Expands its Collaboration with Serono
News

Galapagos Expands its Collaboration with Serono

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Galapagos Expands its Collaboration with Serono "

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Galapagos has announced that its services division BioFocus has reached agreement with the Swiss pharmaceutical company Serono to supply biologically-directed library compounds from its SoftFocus® collection throughout 2005-2006 for Serono's emerging drug discovery programs.

Furthermore, medicinal chemistry services already being provided by BioFocus will be expanded further to accelerate Serono's existing programs.

The combination of BioFocus' and Serono's capabilities have proven to be highly fruitful, and it is envisaged that this increased collaboration will lead to further drug discovery programs between the two companies.
 
Under the terms of the agreement, Galapagos will receive technology access fees for library compounds, plus a fee-for-service component for medicinal chemistry services.
 
“This expanded agreement with Serono fits very well within our strategy to provide integrated drug discovery services to pharma and biotech companies,” said Onno van de Stolpe, Chief Executive Officer of Galapagos.

“We are pleased that our new division BioFocus has been able to secure this important deal for Galapagos.”

Advertisement